Xeljanz Complaints and Complications – Blood Clots and Heart Attacks a Reality
Rheumatoid arthritis is a condition that is thought to be caused by the immune system attacking connective tissue such as tendons, cartilage and even bones. Rheumatoid arthritis can over time cause the degeneration of bone tissue, swelling and even immobility due to the degradation of cartilage which is found in-between bones. This causes bones to come into contact with each other, resulting in excruciating pain. Individuals with rheumatoid arthritis are more likely to have other comorbidities or illnesses such as depression and lupus, and they are usually treated with medication that damp down an overactive immune system such as Xeljanz. Despite its massive success, this anti-arthritis drug has been linked to various cardiovascular events, blood clots and even cancers. It is alleged that the makers of this drug were aware of the negative and life-threatening effects of their medication, but still chose to put it out into the market for public consumption. If you’ve been hurt by Xeljanz, it is vital that you seek out the services of a Xeljanz class action lawsuit law firm such as ours so you can get the justice and compensation you deserve.
Were you harmed by Xeljanz? If you were prescribed Xeljanz for your rheumatoid arthritis and then went on to develop blood clots, stroke or heart attack, we’d love to hear from you. The experienced Xeljanz attorneys at McCready Law have over 90 YEARS of combined experience, at it would be an honor to put this experience to work in solving your case. Xeljanz class action lawsuits are at their infancy, but it is wise to file NOW so that discovery can take place in a timely manner and all the facts pertaining to your case are ironed out well before time. Please call our Xeljanz class action attorneys NOW at (773) 985-5139 to learn more about your legal options for justice and compensation. We take on cases on contingency fee basis, and what this means is that we don’t charge you a CENT as we work on your case, and only do so at the very end of your case once we’ve recovered compensation on your behalf. Were you harmed by Xeljanz? Call us NOW at (773) 985-5139 and we’ll get you started on your legal claim.
Xeljanz is a medication that received FDA approval in 2012 for the treatment of rheumatoid arthritis and ulcerative colitis, of which the first is said to affect 1 percent of the human population. Xeljanz works by blocking certain enzymes which are responsible for alerting the immune system of a threat so that it can launch an attack. By doing so, the immune system doesn’t target joints and tendons, thereby alleviating the inflammation associated with these autoimmune diseases. In addition, the FDA approved the medication to treat colitis and psoriatic arthritis, two conditions which are thought to be caused by an overactive immune system as well.
Some of the most common side-effects associated with Xeljanz include:
- Sinus infections
- Respiratory tract infection
- Low white blood cell count – neutropenia
- Sore throat
- Nasal issues
- High blood pressure
The most severe side-effects associated with Xeljanz include:
- Intestinal perforation
- Blood clots especially in the veins found in the legs
- Heart attacks
- Life-threatening infections
- Liver damage
Suppressing the immune system has the unwanted side-effect of causing blood clots as well as affecting the normal functioning of the heart. Many years after its launch, a slew of lawsuits were launched starting in 2019 by individuals who had started developing deep vein thrombosis and pulmonary embolism.
In addition, the FDA published results of trials which clearly showed a connection between Xeljanz use and heart issues as well as various cancers. The dose didn’t matter, as it was shown that both the 5 and 10mg pills could cause these unwanted complications.
Based off of these clinical trials, the FDA asked Pfizer to add a black box warning on its medication in order to let consumers know about these risks so they can make informed decisions on whether or not they would like to take or continue taking Xeljanz. In addition, patients over the age of 50 were most at risk cardiovascular events while taking Xeljanz. Pfizer only added the black box warning in 2019, seven years after the launch of the medication, and only when it was compelled to do so by the government agency.
Xeljanz has been linked to the following cardiovascular complications:
- Cardiac arrest or heart attack
- Coronary revascularization
- Cardiovascular death
- Myocardial infarction
- Congestive heart failure
In addition, the following cancers have been linked to Xeljanz use:
- Prostate cancer
- Breast cancer
- Lung cancer
- Non-Hodgkin’s lymphoma
- Colon cancer
Xeljanz users have been affected by the following blood clot events:
- Venous thromboembolism
- Arterial thrombosis
- Pulmonary embolism
- Ischemic stroke
Pfizer is alleged to have failed in its duty of care to ensure that you are kept safe from harm by manufacturing medications that don’t have life-threatening side-effects as well as failing to inform the public of these complications in a reasonably timely manner. As a result, consumers such as you can file a Xeljanz lawsuit in order to recover money damages. The various forms of compensation available to Xeljanz victims include the cost of past and future medical care, lost wages due to time spent off work, pain and suffering, loss of consortium or companionship, wrongful death if a loved one died after taking Xeljanz and suffering the conditions named above, legal fees, punitive damages, and so much more.
Xeljanz Blood Clot, Cancer, Heart Attack Lawsuits – Call Us Today!
Ready to speak with a Xeljanz class action lawsuits attorney? Please call (773) 985-5139 NOW to receive your 100% FREE legal consultation into your options for compensation. Remember, the longer you wait, the less likely your case will receive the attention it deserves prior to the consolidation of all cases into a class action lawsuit. Call NOW for your Xeljanz lawsuit assistance. Thanks, and we look forward to helping you.